Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease - Indicators of myocardial ischemic burden?

International Journal of Cardiology

Volumn 120, Issue 2, 2007, Pages 181-187

  Ripa, Rasmus Sejersten ^a   Wang, Yongzhong ^a   Goetze, Jens Peter ^a   Jørgensen, Erik ^a   Johnsen, Hans E ^b   Tägil, Kristina ^c   Hesse, Birger ^a   Kastrup, Jens ^a  

^a University of Copenhagen   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c Department of Clinical Physiology ^*  (Sweden)

Author keywords

Angiogenesis; Diabetes; Endothelial progenitor cell; Ischemic heart disease; Mesenchymal stem cell

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CYTOKINE; ENDOGLIN; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; STROMAL CELL DERIVED FACTOR 1; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANGINA PECTORIS; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; CANADIAN CARDIOVASCULAR SOCIETY ANGINA CLASSIFICATION; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DISEASE MARKER; DISEASE SEVERITY; DYSPNEA; ENDOTHELIUM; EXERCISE TOLERANCE; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; SEATTLE ANGINA PECTORIS QUESTIONNAIRE; STEM CELL; STEM CELL TRANSPLANTATION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; ANTIGENS, CD45; BIOLOGICAL MARKERS; CHRONIC DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; SEVERITY OF ILLNESS INDEX; STEM CELLS;

EID: 34447282760     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.09.011     Document Type: Article

References (33)

1. Grines C.L., Watkins M.W., Helmer G., et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 105 (2002) 1291-1297
2. Henry T.D., Annex B.H., McKendall G.R., et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107 (2003) 1359-1365
3. Kastrup J., Jørgensen E., Drvota V., et al. Intramyocardial injection of genes with a novel percutaneous technique: initial safety data of the Euroinject One Study. Heart Drug 1 (2001) 299-304
4. Kastrup J., Jørgensen E., and Drvota V. Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium. Therapeutic angiogenesis. Scand Cardiovasc J 35 (2001) 291-296
5. Kastrup J. Therapeutic angiogenesis in ischemic heart disease: gene or recombinant vascular growth factor protein therapy?. Curr Gene Ther 3 (2003) 197-206
6. Kastrup J., Jørgensen E., Ruck A., et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol 45 (2005) 982-988
7. Losordo D.W., Vale P.R., Hendel R.C., et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 105 (2002) 2012-2018
8. Ripa R.S., Wang Y., Jørgensen E., Johnsen H.E., Grande P., and Kastrup J. Safety of bone-marrow stem cell mobilisation induced by granulocyte-colony stimulating factor: clinical 30 days blinded results from the stem cells in myocardial infarction (STEMMI) trial. Heart Drug 5 (2005) 177-182
9. Ripa R.S., Jørgensen E., Wang Y., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113 (2006) 1983-1992
10. Schachinger V., Assmus B., Britten M.B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44 (2004) 1690-1699
11. Simons M., Annex B.H., Laham R.J., et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105 (2002) 788-793
12. Vale P.R., Losordo D.W., Milliken C.E., et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 103 (2001) 2138-2143
13. Wang Y., Tägil K., Ripa R.S., et al. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. Int J Cardiol 100 (2005) 477-483
14. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
15. Soeki T., Tamura Y., Shinohara H., Tanaka H., Bando K., and Fukuda N. Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease. Heart Vessels 15 (2000) 105-111
16. Hesse B., Tagil K., Cuocolo A., et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 32 (2005) 855-897
17. Mancuso P., Burlini A., Pruneri G., Goldhirsch A., Martinelli G., and Bertolini F. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 97 (2001) 3658-3661
18. Goetze J.P., Kastrup J., Pedersen F., and Rehfeld J.F. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 48 (2002) 1035-1042
19. Wang Y., Johnsen H.E., Mortensen S., et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 92 (2006) 768-774
20. Lee S.H., Wolf P.L., Escudero R., Deutsch R., Jamieson S.W., and Thistlethwaite P.A. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342 (2000) 626-633
21. Wang Y., Gabrielsen A., Lawler P.R., et al. Myocardial gene expression of angiogenic factors in human chronic ischemic myocardium: influence of acute ischemia/cardioplegia and reperfusion. Microcirculation 13 (2006) 187-197
22. Schultz A., Lavie L., Hochberg I., et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 100 (1999) 547-552
23. Lambiase P.D., Edwards R.J., Anthopoulos P., et al. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 109 (2004) 2986-2992
24. Yongzhong W., Johnsen H.E., Jørgensen E., and Kastrup J. The clinical impact of vascular growth factors and endothelial progenitor cells in the acute coronary syndrome. Scand Cardiovasc J 37 (2003) 18-22
25. Juarez J., Bendall L., and Bradstock K. Chemokines and their receptors as therapeutic targets: the role of the SDF-1/CXCR4 axis. Curr Pharm Des 10 (2004) 1245-1259
26. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (2003) 1322-1328
27. Damas J.K., Waehre T., Yndestad A., et al. Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation 106 (2002) 36-42
28. Meleth A.D., Agron E., Chan C.C., et al. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 46 (2005) 4295-4301
29. Shirozu M., Nakano T., Inazawa J., et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28 (1995) 495-500
30. Butler J.M., Guthrie S.M., Koc M., et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 115 (2005) 86-93
31. Massa M., Rosti V., Ferrario M., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105 (2005) 199-206
32. Valgimigli M., Rigolin G.M., Fucili A., et al. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110 (2004) 1209-1212
33. Eizawa T., Ikeda U., Murakami Y., et al. Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease. Heart 90 (2004) 685-686